3M Health Care’s Medical Solutions Division has advanced the delivery of 3M Veraflo Therapy. A new 3M Veraflo Cleanse Choice Complete Dressing Kit and a software upgrade for the 3M V.A.C. Ulta Therapy Unit was introduced at no increase cost to the customer. These new offerings help simplify the care delivery processes for clinicians using Veraflo Therapy (negative pressure wound therapy with instillation) and help make dressing changes easier, faster, and less painful for their patients as compared to previous Veraflo Therapy dressings.
Also Read: Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery
Wound care experts use Veraflo Therapy for patients with open soft tissue wounds to help cleanse and stimulate formation of granulation tissue. A recent publication by Gabriel et al Effects of Negative-Pressure Wound Therapy with Instillation versus Standard of Care in Multiple Wound Types: Systematic Literature Review and Meta-Analysis, shows that Veraflo Therapy demonstrated significant clinical advantages and economic savings versus other advanced wound therapies, including traditional negative pressure wound therapy (NPWT). When Veraflo Cleanse Choice Complete Dressing is used in conjunction with Veraflo Therapy, the combination helps to disrupt, soften, solubilize and remove thick, exudate and non-viable tissue when immediate wound cleansing is needed or when surgical debridement must be delayed or is not possible.
“3M offers a broad range of wound care solutions because clinicians need a robust tool selection,” said Ronald Silverman, M.D., 3M Health Care senior vice president of clinical affairs and chief medical officer. “We continue to find ways to innovate to meet their unique wound care needs and address the changing nature of wound care. Today’s wound care patients are often sicker and have more comorbidities, making their wounds more complex to treat and increasing the demands on clinicians’ time. We strive to make our products easier to use to help save clinicians’ valuable time and, ultimately, transform patient outcomes and improve their lives.”